Figure 1.
Figure 1. Risk for CNS relapse by CNS-IPI categories. (A) Overall GOYA study population (N = 1418); (B) population with COO data available (n = 933). EoT, end of treatment.

Risk for CNS relapse by CNS-IPI categories. (A) Overall GOYA study population (N = 1418); (B) population with COO data available (n = 933). EoT, end of treatment.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal